Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma. (Q40073685)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma. |
scientific article |
Statements
Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma (English)
Fabio Gasparri
Arturo Galvani
Linda Nici
James W Darnowski
Dario Barbone
Dean A Fennell
Giovanni Gaudino
Luciano Mutti
1 October 2007